Filing Flows

Filing Flows › Companies › Zymeworks › Timeline

Zymeworks stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+65.6% to $29.63

Zymeworks (ZYME) stock rose 66% over the last 252 sessions, to $29.63. On the way it reported 4 quarters, its insiders filed 8 open-market trades and 1 Form 144 notice of planned sales, and the company filed 7 material 8-Ks. Each is marked on the price and listed with what the stock did next.

ZYME: a year of the stock with every disclosure on itZYME: a year of the stock with every disclosure on it$19.51$23.74$27.98$32.21●2025-11-06 · Earnings: beat the EPS estimate by 17.8%◆2025-11-18 · Directors and officers: departures, appointments, pay▼2025-12-22 · Galbraith Kenneth sold $1.3M▼2026-01-05 · Galbraith Kenneth sold $1.4M▼2026-01-05 · Moore Paul Andrew sold $505K▼2026-01-05 · Smith Jeffrey T L sold $265K▼2026-01-12 · Galbraith Kenneth sold $690K▼2026-01-12 · Hollywood Mark sold $139K▼2026-01-12 · Moore Paul Andrew sold $217K▼2026-01-12 · Smith Jeffrey T L sold $211K◆2026-01-12 · Directors and officers: departures, appointments, pay●2026-03-02 · Earnings: missed the EPS estimate by -70.6%◆2026-03-02 · Material definitive agreement◆2026-04-01 · Directors and officers: departures, appointments, pay●2026-05-07 · Earnings: missed the EPS estimate by -484.3%◆2026-06-29 · Material definitive agreement●2026-08-06 · Earnings: missed the EPS estimate by -4.8%◆2026-09-23 · Material definitive agreement▽2026-10-09 · Form 144: Adam Schayowitz plans to sell $349K◆2026-10-23 · Material definitive agreement●Earnings report◆8-K event▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Oct 23, 20268-KMaterial definitive agreement−0.8% (−0.3% vs SPY)+0.9% (+0.2% vs SPY)—
Oct 9, 2026Form 144Form 144: Adam Schayowitz plans to sell $349K+2.1% (+1.5% vs SPY)+1.9% (+2.2% vs SPY)+16.0% (+21.1% vs SPY)
Sep 23, 20268-KMaterial definitive agreement−2.5% (−2.5% vs SPY)−3.7% (−3.1% vs SPY)+3.4% (+3.9% vs SPY)
Aug 6, 2026EarningsEarnings: missed the EPS estimate by -4.8%−1.6% (−1.4% vs SPY)+5.9% (+5.6% vs SPY)+24.1% (+23.7% vs SPY)
Jun 29, 20268-KMaterial definitive agreement−0.2% (−1.8% vs SPY)+4.8% (+1.8% vs SPY)−6.6% (−8.2% vs SPY)
May 7, 2026EarningsEarnings: missed the EPS estimate by -484.3%−3.7% (−3.4% vs SPY)−11.7% (−12.8% vs SPY)−13.8% (−14.4% vs SPY)
Apr 1, 20268-KDirectors and officers: departures, appointments, pay+3.5% (+2.8% vs SPY)+6.5% (+2.6% vs SPY)+9.5% (−0.5% vs SPY)
Mar 2, 20268-KMaterial definitive agreement+0.1% (0.0% vs SPY)+3.3% (+5.3% vs SPY)+3.9% (+11.8% vs SPY)
Mar 2, 2026EarningsEarnings: missed the EPS estimate by -70.6%+0.1% (0.0% vs SPY)+3.3% (+5.3% vs SPY)+3.9% (+11.8% vs SPY)
Jan 12, 20268-KDirectors and officers: departures, appointments, pay+3.2% (+3.4% vs SPY)+2.2% (+4.7% vs SPY)−1.4% (−1.0% vs SPY)
Jan 12, 2026Insider saleSmith Jeffrey T L sold $211K0.0% (−0.2% vs SPY)+1.3% (+1.6% vs SPY)−1.9% (−1.6% vs SPY)
Jan 12, 2026Insider saleMoore Paul Andrew sold $217K0.0% (−0.2% vs SPY)+1.3% (+1.6% vs SPY)−1.9% (−1.6% vs SPY)
Jan 12, 2026Insider saleHollywood Mark sold $139K0.0% (−0.2% vs SPY)+1.3% (+1.6% vs SPY)−1.9% (−1.6% vs SPY)
Jan 12, 2026Insider saleGalbraith Kenneth sold $690K0.0% (−0.2% vs SPY)+1.3% (+1.6% vs SPY)−1.9% (−1.6% vs SPY)
Jan 5, 2026Insider saleSmith Jeffrey T L sold $265K−4.4% (−5.0% vs SPY)−13.9% (−15.5% vs SPY)−12.7% (−13.7% vs SPY)
Jan 5, 2026Insider saleMoore Paul Andrew sold $505K−4.4% (−5.0% vs SPY)−13.9% (−15.5% vs SPY)−12.7% (−13.7% vs SPY)
Jan 5, 2026Insider saleGalbraith Kenneth sold $1.4M−4.4% (−5.0% vs SPY)−13.9% (−15.5% vs SPY)−12.7% (−13.7% vs SPY)
Dec 22, 2025Insider saleGalbraith Kenneth sold $1.3M+1.4% (+0.8% vs SPY)−1.8% (−2.9% vs SPY)−14.5% (−15.7% vs SPY)
Nov 18, 20258-KDirectors and officers: departures, appointments, pay−3.9% (−3.0% vs SPY)+4.5% (+4.0% vs SPY)+6.8% (+6.0% vs SPY)
Nov 6, 2025EarningsEarnings: beat the EPS estimate by 17.8%−0.8% (+0.3% vs SPY)+7.1% (+6.2% vs SPY)+39.1% (+37.9% vs SPY)

Insiders’ record here

In the year on the chart, Zymeworks' insiders reported 0 open-market buys ($0) and 8 sales ($4.7M). Of the 8 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale +16.6%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%
2.03 New debt or off-balance-sheet obligation13,2680.0%50%+1.2%±1.3%
2.01 Completed acquisition or disposition2,671+0.1%52%+1.2%±1.6%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Zymeworks: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.